Dwivedi P P, Muscat G E, Bailey P J, Omdahl J L, May B K
Department of Biochemistry, University of Adelaide, South Australia, Australia.
J Mol Endocrinol. 1998 Jun;20(3):327-35. doi: 10.1677/jme.0.0200327.
Repression of basal transcription of a 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) responsive 25-hydroxyvitamin D3-24-hydroxylase (CYP24) promoter construct as observed in kidney cells in the absence of ligand and this repression was dependent on a functional vitamin D response element (VDRE). Basal repression was also seen with a construct where a consensus DR-3-type VDRE was fused to the thymidine kinase promoter. Expression of a dominant negative vitamin D receptor (VDR) isoform that strongly bound to the VDRE motif in the CYP24 promoter ablated basal repression. This VDR isoform lacked sequence in the hinge- and ligand-binding domains implicating one or both of these domains in basal repression. It is well known that thyroid hormone and retinoic acid receptors silence basal transcription of target genes in the absence of ligands and this repressor function can be mediated by the nuclear receptor corepressor N-CoR. Two variants of N-CoR have been described, RIP13a and RIP13delta1. N-CoR and the variants contain two receptor interaction domains, ID-I and ID-II, which are identical except region ID-II in RIP13delta1 has an internal deletion. We have used the mammalian two hybrid system to investigate whether VDR, in the absence of ligand 1,25-(OH)2D3, can interact with these domains. The data showed that unliganded VDR does not interact with either ID-I or ID-II from RIP13a and RIP13delta1, but does interact strongly with a composite domain of ID-I and ID-II from RIP13delta1 (but not from RIP13a) and this strong interaction is abrogated in the presence of ligand. This finding implicates RIP13delta1 in VDR-dependent basal repression of the promoter constructs under investigation. However, over-expression of RIP13delta1 in kidney cell lines did not alter basal expression of the CYP24 promoter construct. It is concluded that either the level of endogenous RIP13delta1 in these kidney cells permits maximal repression or that repression occurs by a mechanism that is independent of RIP13delta1. Alternatively, repression may be dependent on RIP13delta1 but requires an additional cofactor that is limiting in these cells.
在缺乏配体的情况下,在肾细胞中观察到1,25 - 二羟基维生素D3(1,25-(OH)2D3)反应性25 - 羟基维生素D3 - 24 - 羟化酶(CYP24)启动子构建体的基础转录受到抑制,且这种抑制依赖于功能性维生素D反应元件(VDRE)。在一个构建体中也观察到基础抑制,该构建体将一个共有DR - 3型VDRE与胸苷激酶启动子融合。一种与CYP24启动子中的VDRE基序强烈结合的显性负性维生素D受体(VDR)异构体的表达消除了基础抑制。这种VDR异构体在铰链区和配体结合区缺乏序列,这表明这些区域中的一个或两个与基础抑制有关。众所周知,甲状腺激素和视黄酸受体在缺乏配体时会使靶基因的基础转录沉默,这种阻遏功能可由核受体共抑制因子N - CoR介导。已经描述了N - CoR的两种变体,RIP13a和RIP13delta1。N - CoR及其变体包含两个受体相互作用结构域,ID - I和ID - II,除了RIP13delta1中的ID - II区域有一个内部缺失外,它们是相同的。我们使用哺乳动物双杂交系统来研究在缺乏配体1,25-(OH)2D3的情况下,VDR是否能与这些结构域相互作用。数据表明,未结合配体的VDR不与RIP13a和RIP13delta1的ID - I或ID - II相互作用,但确实与RIP13delta1(而非RIP13a)的ID - I和ID - II的复合结构域强烈相互作用,并且在存在配体的情况下这种强烈相互作用被消除。这一发现表明RIP13delta1参与了所研究的启动子构建体的VDR依赖性基础抑制。然而,在肾细胞系中过表达RIP13delta1并没有改变CYP24启动子构建体的基础表达。得出的结论是,要么这些肾细胞中内源性RIP13delta1的水平允许最大程度的抑制,要么抑制是通过一种独立于RIP13delta1的机制发生的。或者,抑制可能依赖于RIP13delta1,但需要一种在这些细胞中有限的额外辅因子。